ALMB-0166

· AlaMab Therapeutics (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALMB-0166, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury [Phase 1]

See pricing